In this Issue:
The Strategic Timing of Antiretroviral Treatment (START) study
WAVES study data elucidate HIV-1 regimens for women
Doravirine vs efavirenz in ART-naïve HIV infection
Atripla® single tablet vs multiple tablet regimen
A lower dose atazanavir/ritonavir regimen in Thai HIV patients
Switch to Stribild-TAF vs continue TDF
Switching Atripla® to boosted darunavir monotherapy
Switch renally impaired from TDF to TAF?
Antiviral activity and safety with BMS maturation inhibitor
Daily vs intermittent PrEP in MSM and TGW
. . . and in Thai MSM
Please login below to download this issue (PDF)